Tyler Jacks

David H Koch Professor
Department
David H Koch Institute for Integrative Cancer Res
Technology Areas
Therapeutics: Small Molecules, Proteins & Antibodies, Nucleic Acids, Vaccines / Biotechnology: Biomedical Devices & Systems / Diagnostics: Assays / Chemicals & Materials: Nanotechnology & Nanomaterials
Impact Areas
Healthy Living, Uncharted Frontiers

Technologies

Augmentation of T and B Cell Activation with a Novel Cysteine Protease Linker Sequence

Technology / Case number: #25338
Sean-Luc Shanahan / Tyler Jacks
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Targeting Lung Microbiota and its Responding Immune Pathways for Lung Cancer Treatment

Technology / Case number: #20602HRJ
Paul Blainey / Chengcheng Jin / Georgia Lagoudas / Tyler Jacks
Technology Areas: Diagnostics / Therapeutics
Impact Areas: Healthy Living
License

Enhancing tumor immunogenicity with Hsp90 inhibition

Technology / Case number: #20303WHJ
Luke Whitesell / Alexander Jaeger / Sandro Santagata / Tyler Jacks / Susan Lindquist
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living, Uncharted Frontiers
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up